Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

Sheba Medical Center

Status: Unknown

Conditions: Graft Versus Host Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00912067

SHEBA-09-7085-IB-CTIL

Details and patient eligibility

About

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Enrollment: 120 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• after hematopoietic stem cell transplantation done at sheba medical center Israel
• 3 month have past from transplantation but no more then 3 years

Exclusion criteria

• transplantation done in the last 3 month or more than 3 years have past since

Trial design

120 participants in 1 patient group

hematopoietic stem cell transplantation